节点文献

国医大师韩明向从“虚-痰-瘀”辨治慢性肺系疾病

TCM master HAN Mingxiang in differentiation and treatment of chronic lung diseases from ‘deficiency-phlegm-stasis’

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 马啸王芬梁雪徐淑钰张璐石孟瑶韩明向李泽庚

【Author】 MA Xiao;WANG Fen;LIANG Xue;XU Shuyu;ZHANG Lu;SHI Mengyao;HAN Mingxiang;LI Zegeng;Anhui University of Chinese Medicine;Department of Respiratory and Critical Medicine, Wuhu Traditional Chinese Medicine Hospital;Department of Geriatric Endocrinology, The First Affiliated Hospital of Anhui Medical University;Anhui Province Hospital of Chinese Medicine;Institute of Respiratory Disease Prevention and Treatment of Chinese Medicine, Anhui Academy of Chinese Medicine;

【通讯作者】 李泽庚;

【机构】 安徽中医药大学芜湖市中医医院呼吸与危重症医学科安徽医科大学第一附属医院老年内分泌科安徽省中医院安徽省中医药科学院中医呼吸病防治研究所

【摘要】 文章以具体病案为导向对国医大师韩明向教授辨治慢性肺系疾病的临床经验进行分析总结。韩教授认为慢性肺系疾病大多是虚实夹杂、本虚标实的证候。其中气阴两虚为疾病的根本原因及始动因素,痰饮内停、瘀血阻络为疾病反复发作的核心和病理因素。并根据疾病特点提出了慢性肺系疾病“虚-痰-瘀”的病机演变规律。韩教授提出临证应以补肺益气、养阴增液治其本,以行气祛痰、活血化瘀治其标,最终达到标本兼顾、扶正祛邪的目的。

【Abstract】 This paper analyzes and summarizes the clinical experience of professor HAN Mingxiang, a TCM master, in identifying and treating chronic pulmonary diseases using specific cases as an orientation. According to professor HAN, most of the chronic lung diseases are characterized by a mixture of deficiencies and realities. Among them, deficiency of qi and yin is the root cause and initiating factor of the disease, while phlegm-beverage internalization and blood stasis are the core and pathological factors of recurrent disease episodes. According to the characteristics of the disease, the pathogenesis of chronic pulmonary diseases, which is ‘deficiency-phlegm-stasis’, is proposed. Professor HAN suggested that clinical treatment should be based on tonifying the lungs, nourishing the yin and increasing the fluid, moving the qi and expelling the phlegm, activating the blood and removing the blood stasis to treat the symptoms, so as to achieve the goal of combining the symptoms and the essence and supporting the correctness and eliminating the evils.

【基金】 国家自然科学基金区域创新重点项目(No.U20A20398);安徽省科技重大专项(No.201903a07020015);2021年度安徽中医药大学临床科研项目(No.2021LCWH03);2022年安徽省临床医学研究转化专项(No.202204295107020045)
  • 【文献出处】 中华中医药杂志 ,China Journal of Traditional Chinese Medicine and Pharmacy , 编辑部邮箱 ,2024年12期
  • 【分类号】R256.1;R249
  • 【下载频次】105
节点文献中: 

本文链接的文献网络图示:

本文的引文网络